Pershing Square Capital Management Portfolio holdings
Pershing Square Capital Management, L.P., founded in 2004 by Bill Ackman and headquartered in New York City, is a prominent American hedge fund known for its concentrated, activist investment approach, managing over $18 billion in assets as of recent years. Starting with $54 million from Ackman’s personal funds and a seed investment from Leucadia National, the firm focuses on acquiring significant stakes in a small portfolio of large-cap North American companies, often pushing for operational and governance changes to unlock shareholder value, as seen in high-profile campaigns targeting Wendy’s, McDonald’s, and Herbalife. In 2014, Ackman launched Pershing Square Holdings, a closed-end fund listed on Euronext Amsterdam and the London Stock Exchange, raising $3 billion in its IPO, providing a permanent capital base to support its long-term strategies. Renowned for bold moves—like a $2.6 billion profit betting on a market crash in 2020—and a research-intensive, value-driven philosophy, Pershing Square has solidified its reputation as a formidable player in the investment world under Ackman’s leadership.
Top Buys
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$401M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 43.91% |
| 2 | Materials | 27.03% |
| 3 | Industrials | 15.46% |
| 4 | Consumer Discretionary | 10.05% |
| 5 | Real Estate | 3.55% |
Similar funds
Pershing Square Capital Management's Q2 2015 Portfolio in Review
As of Q2 2015, Pershing Square Capital Management held 8 positions worth $14.4B, down 3.5% from $15B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Pershing Square Capital Management's Q2 2015 filing shows 1 closed position. The largest sale was Allergan plc, an estimated $401M.
By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 41% a quarter earlier, followed by Materials and Industrials.
- Pershing Square Capital Management fully exited Allergan plc in Q2 2015, selling an estimated $401M.
- Pershing Square Capital Management's ten largest holdings make up 100% of its $14.4B portfolio in Q2 2015.
- Pershing Square Capital Management opened 0 new positions and closed 1 in Q2 2015.
- Pershing Square Capital Management's portfolio value fell 3.5% quarter-over-quarter to $14.4B.
Based on Pershing Square Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.